To evaluate the serum levels of tumour-associated antigens (TAAs) in patients with SSc and interstitial lung disease (ILD) and to define whether their levels mirror the severity and the progression of lung damage.
De Luca, G., Bosello, S. L., Berardi, G., Rucco, M., Canestrari, G. B., Correra, M., Mirone, L., Forni, F., Di Mario, C., Danza, F., Pirronti, T., Ferraccioli, G., Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk, <<RHEUMATOLOGY>>, 2015; 54 (11): 1991-1999. [doi:10.1093/rheumatology/kev204] [http://hdl.handle.net/10807/71463]
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk
De Luca, Giacomo;Bosello, Silvia Laura;Berardi, Giorgia;Rucco, Manuela;Canestrari, Giovanni Battista;Correra, Miriam;Mirone, Luisa;Forni, Franca;Di Mario, Clara;Danza, Francesco;Pirronti, Tommaso;Ferraccioli, Gianfranco
2015
Abstract
To evaluate the serum levels of tumour-associated antigens (TAAs) in patients with SSc and interstitial lung disease (ILD) and to define whether their levels mirror the severity and the progression of lung damage.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
